Table 4.

Number of Cardiovascular Events per Participant among the Groups

CV Events	Remission Group (N=208)		Non-Remission Group (N=194)
	Sertraline	Placebo	Sertraline	Placebo
Any non-fatal cardiovascular eventa	1.04±1.73	1.18±1.86	1.82±3.08	1.52±2.28
Acute Myocardial Infarction	0.04±0.19	0.07±0.29	0.07±0.29	0.02±0.14
Exacerbation of Heart Failure	0.42±1.05	0.57±1.40	0.88±2.02	0.70±1.34
Unstable Angina Pectoris	0.11±0.48	0.07±0.39	0.20±0.62	0.18±0.63
Arrhythmia	0.05±0.25	0.11±0.37	0.20±0.71	0.14±0.53
Syncope	0.04±0.19	0±	0.01±0.11	0.05±0.21
Stroke	0.05±0.25	0.03±0.22	0.06±0.23	0.04±0.21
Transient Ischemic Attack	0±	0±	0.02±0.15	0±
Other	0.36±0.81	0.32±0.64	0.40±0.96	0.42±0.83
Any cardiovascular event and/or deathb	1.27±1.81	1.40±1.90	2.1±3.13	1.79±2.3

^aAdjusted p- value = .02;

^bAdjusted p- value = .01 for comparisons between the remission and the non-remission groups.